PARIS (MedPage Today) — Patients with Sjogren’s syndrome had more than double the heart attack risk seen in the general population, a researcher reported here.
Category: News
Screen for Hydroxychloroquine Retinopathy to Preserve Vision
Hydroxychloroquine retinopathy can cause damage that may continue for 3 or more years after the drug is discontinued and greatly reduce the amount of visual loss. Medscape Medical News
Cranial ultrasound has greater sensitivity than temporal artery biopsy in diagnosis of GCA
A new study presented for the first time today at the European League Against Rheumatism Annual Congress (EULAR 2014), shows that cranial ultrasound has a greater sensitivity than temporal artery biopsy,* and a comparable specificity in the diagnosis o…
The Course of Retinal Vasculitis
Gain a better understanding of the clinical course and prognosis of retinal vasculitis. The British Journal of Ophthalmology
New research shows that good design improves the independence of people with dementia and sight loss
New guidelines launched by the sight loss charity, Thomas Pocklington Trust and the University of Stirling, reveal how clever design of living spaces can improve the lives of people who are living…
The First EMR to Integrate with Watson (INTERVIEW)
At Medgadget we’re optimistic about the potential of IBM‘s Watson computer to improve clinical workflow and efficiency, which is why we were excited to learn about the first integration of Watson into an EMR. Modernizing Medicine has staked its claim in a relatively crowded EMR space by focusing on specialty-based medicin (Read more...)
NSU College of Optometry investigators awarded NIH grant to study convergence insufficiency
The National Eye Institute of the National Institutes of Health has awarded up to $556,532 to investigators at Nova Southeastern University’s College of Optometry to study the relationship between the vision condition, convergence insufficiency, and re…
Researchers create three-dimensional complement of human retinal tissue in a dish
Using a type of human stem cell, Johns Hopkins researchers say they have created a three-dimensional complement of human retinal tissue in the laboratory, which notably includes functioning photoreceptor cells capable of responding to light, the first …
Financial Return-on-Investment of Ophthalmic Interventions
Are ophthalmic interventions worth the investment? Current Opinion in Ophthalmology
Light-sensitive retina created with human stem cells
With human stem cells, a team has created a miniature human retina in a petri dish with functioning photoreceptor cells. They hope this technique could restore vision one day.
FDA Panel Delivers Mixed Verdict on KAMRA Corneal Inlay
The FDA’s Ophthalmic Devices Advisory Committee wrestled with flawed trial data that suggested efficacy but yielded some safety concerns, leading to overall uncertainty about benefit versus risk. Medscape Medical News
Anti-VEGF Agents for Proliferative Diabetic Retinopathy
This review summarizes evidence on the use of anti-VEGF agents in the treatment of proliferative diabetic retinopathy. Eye
How to Make a Difficult Capsulotomy Routine
With the femtosecond laser, this capsulotomy is in the bag. Medscape Ophthalmology
UAB ophthalmologists offer safety tips to prevent firework related injuries
Fourth of July 2013: Family members were shooting fireworks in the backyard of Dianne Peterson’s home in Vincent, Alabama, as she walked out of the house.
Study could help improve retinal prosthetic devices
In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object.
Jigsaw effect in glaucoma patients proves it is a brain disease
Findings from a new study published in Translational Vision Science & Technology (TVST show the brain, not the eye, controls the cellular process that leads to glaucoma.
How doctor is paid can affect diabetes care
From 2006 to 2008, nearly 75 per cent of Ontarians with diabetes did not receive all of the tests recommended to properly monitor their disease.
AMD: Baseline Vision Features May Predict Vision Loss
Sustained visual acuity loss may be rare in patients with AMD treated with anti-VEGF drugs, but baseline vision characteristics may predict patients whose vision will worsen. Medscape Medical News
Long-term Outcomes of Intravitreal Injections for AMD
Sadly, good 2-year results don’t always translate into good long-term results. Medscape Ophthalmology
Study: The brain controls cellular process that leads to glaucoma
Findings from a new study published in Translational Vision Science & Technology show the brain, not the eye, controls the cellular process that leads to glaucoma. The results may help develop treatments for one of the world’s leading causes of irreversible blindness, as well as contribute to the development of future therapies for preserving brain function in other age-related disorders like Alzheimer’s.